<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="8333" whole_study_id="6087" phs="000257" v="3" p="1" createDate="2012-07-26T14:29:51-05:00" modDate="2019-07-19T13:31:03-05:00" maxParentChildStudyModDate="2019-07-19T13:31:03-05:00" handle="HMP_GutCrohnsFnc" num_participants="36"><StudyInfo accession="phs000257.v3.p1" parentAccession="phs000257.v3.p1"><BioProject id="PRJNA46321" entrez_id="46321" type="bp_data_submission"/><BioProject id="PRJNA74957" entrez_id="74957" type="bp_admin_access"/><StudyNameEntrez>Metagenomic Analysis of the Structure and Function of the Human Gut Microbiota in Crohn's Disease</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>UH2 DK083991-01</Funding></StudyInfo><Authority><ICs><IC id="11" name="NIDDK" is_funding_ic="false" is_admin_ic="false" primary="true"/><IC id="22" name="OD" is_funding_ic="false" is_admin_ic="false"/></ICs><Persons><Person nedid="CMFRASER" aid="2" auth="eRA" login="CMFRASER" fname="Claire" mname="M" lname="Fraser-Liggett" email="cmfraser@som.umaryland.edu"><Role>PI</Role><Organization>UNIVERSITY OF MARYLAND BALTIMOREINSTITUTE FOR GENOMIC RESEARCH</Organization></Person><Person nedid="0010067753" aid="1" auth="cit" login="karpr" fname="Robert" mname="W" lname="Karp" email="karpr@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013043239" aid="1" auth="cit" login="pretels" fname="Renate" mname="S" lname="Pretel" email="pretels@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>INSTRUCTIONS:  This study has not provided a suggested acknowledgement statement. However, Approved Users are expected to acknowledge the Submitting Investigator(s) who submitted data from the original study to an NIH-designated data repository, the primary funding organization that supported the Submitting Investigator(s), and the NIH-designated data repository (e.g., dbGaP).  The acknowledgment statement should include the dbGaP accession number to the specific version of the dataset(s) analyzed.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="739" CGType="cg_class_other" title="Microbiome" name="HMP" dac_uid="60" dac_name="NIDDK" irb-approval-required="No"><Use-Restriction>Studies related to the human microbiome.
Sequence data generated from microbiome samples will be used only for the purpose of studying the microbial components of the microbiome and will not be used to make inferences about the human host DNA itself.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="7730" whole_study_id="6087" phs="000257" v="2" p="1" createDate="2012-03-02T10:55:51-05:00" modDate="2020-09-01T09:58:27-05:00" maxParentChildStudyModDate="2020-09-01T09:58:27-05:00" handle="HMP_GutCrohnsFnc" num_participants="36"><StudyInfo accession="phs000257.v2.p1" parentAccession="phs000257.v2.p1"><BioProject id="PRJNA46321" entrez_id="46321" type="bp_data_submission"/><BioProject id="PRJNA74957" entrez_id="74957" type="bp_admin_access"/><StudyNameEntrez>Metagenomic Analysis of the Structure and Function of the Human Gut Microbiota in Crohn's Disease</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>UH2 DK083991-01</Funding></StudyInfo><Authority><ICs><IC id="11" name="NIDDK" is_funding_ic="false" is_admin_ic="false" primary="true"/><IC id="22" name="OD" is_funding_ic="false" is_admin_ic="false"/></ICs><Persons><Person nedid="CMFRASER" aid="2" auth="eRA" login="CMFRASER" fname="Claire" mname="M" lname="Fraser-Liggett" email="cmfraser@som.umaryland.edu"><Role>PI</Role><Organization>UNIVERSITY OF MARYLAND BALTIMOREINSTITUTE FOR GENOMIC RESEARCH</Organization></Person><Person nedid="0010067753" aid="1" auth="cit" login="karpr" fname="Robert" mname="W" lname="Karp" email="karpr@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013043239" aid="1" auth="cit" login="pretels" fname="Renate" mname="S" lname="Pretel" email="pretels@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><DUC><File uri="dbgapssws.cgi?blob_id=6202&amp;file=get&amp;page=file" filename="HMP_GutCrohnsFnc_Fraser_DUC.doc" md5="6632269ad9e3183045b7eede03211835" size="69632" modDate="2010-06-02T16:16:29-05:00" content-type="application/msword"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=16662&amp;file=get&amp;page=file" filename="HMP_GutCrohnsFnc_Fraser_DUC.doc.pdf" md5="125cc39c00792277472a29ad4753e7a4" size="122630" modDate="2015-08-31T16:16:05-05:00" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="739" CGType="cg_class_other" title="Microbiome" name="HMP" dac_uid="60" dac_name="NIDDK" irb-approval-required="No"><Use-Restriction>Studies related to the human microbiome.
Sequence data generated from microbiome samples will be used only for the purpose of studying the microbial components of the microbiome and will not be used to make inferences about the human host DNA itself.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="6087" whole_study_id="6087" phs="000257" v="1" p="1" createDate="2010-04-02T18:05:08-05:00" modDate="2020-09-01T11:35:06-05:00" maxParentChildStudyModDate="2020-09-01T11:35:06-05:00" handle="HMP_GutCrohnsFnc" num_participants="36"><StudyInfo accession="phs000257.v1.p1" parentAccession="phs000257.v1.p1"><BioProject id="PRJNA46321" entrez_id="46321" type="bp_data_submission"/><BioProject id="PRJNA74957" entrez_id="74957" type="bp_admin_access"/><StudyNameEntrez>Metagenomic Analysis of the Structure and Function of the Human Gut Microbiota in Crohn's Disease</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>sra</StudyType></StudyTypes><SraStorages/><Description>
&lt;p&gt;Inflammatory bowel diseases (IBD), such as Crohn&amp;#39;s disease, are chronic, immunologically mediated disorders that have  severe medical consequences. The current hypothesis is that these diseases are due to an overly aggressive immune  response to a subset of commensal enteric bacteria. Studies to date on IBD have suggested that the disorder may be  caused by a combination of bacteria and host susceptibility; however the etiologies of these diseases remain an  enigma. In this application, we propose to develop and demonstrate the ability to profile Crohn&amp;#39;s disease at an  unprecedented molecular level by elucidation of specific biomarkers (bacterial strains, genes, or proteins) that  correlate to disease symptoms. To achieve this goal, we will employ a multidisciplinary approach based on metagenomic  and metaproteomic molecular tools to elucidate the composition of the commensal microbiota in monozygotic twins  that are either healthy or exhibit Crohn&amp;#39;s disease (for concordant, both are diseased; for discordant, one is  healthy and one is diseased). The central hypotheses of this proposal are (1) that specific members and/or  functional activities of the gastrointestinal (GI) microbiota differ in patients with Crohn&amp;#39;s disease as  compared to healthy individuals, and (2) that it will be possible to elucidate microbial signatures which  correlate with the occurrence and progression of this disease by integration of data obtained from 16S rRNA-based  molecular fingerprinting, metagenomics, and metaproteomics approaches. To address these hypotheses, three specific  aims are proposed: 1) Obtain data on community gene content (metagenome) in a subset of healthy twins and twins with  Crohn&amp;#39;s Disease to assess potential differences in the metabolic capabilities of the gut microbiota associated with  CD, 2) Obtain data on community protein content (metaproteome) in a subset of healthy twins and twins with Crohn&amp;#39;s  Disease to assess the state of expressed proteins associated with CD, 3) Apply various statistical clustering and  classification methods to correlate/associate microbial community composition, gene and protein content with patient  metadata, including metabolite profiles and clinical phenotype. The ultimate goal of these efforts is to identify novel  biomarkers for non-invasive diagnostics of CD and to eventually identify drug targets (i.e. bacterial strains) for  cure or suppression of disease symptoms. PUBLIC HEALTH RELEVANCE: This study aims to unravel the contribution of  the bacteria that normally inhabit the human gastrointestinal tract to Crohn&amp;#39;s disease by using a multidisciplinary  approach to study changes in the structure and function of gut microbial communities in three sets of patient cohorts  who have Crohn&amp;#39;s disease. These results will be compared with those obtained from the study of healthy individuals  and have the potential to identify new biomarkers of disease severity, location, and progression.&lt;/p&gt;
 </Description><StudyHistory>
&lt;p&gt;Inflammatory bowel diseases (IBD) are increasing in prevalence in Europe and North America (current  estimates are approximately 0.4% of the population (Loftus, 2004, PMID:  &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/15168363" target="_blank"&gt;15168363&lt;/a&gt;), which likely is due in part to the Western  lifestyle.  IBD can be divided into two categories: Ulcerative Colitis (UC) and Crohn&amp;#39;s Disease (CD).  Both are  chronic, relapsing, immunologically mediated disorders that can have severe physical consequences. This study  describes research that will combine state-of-the-art experimental and computational methods to characterize  variation in the gut microbiota in CD at a level never before possible.  At the present, there are virtually  no other reports that have addressed the complex aspects of this severe disease by studying both microbial  community structure and function.  A microbial involvement in the etiology of CD has been suggested,  characterized, in part, by an imbalance between beneficial and detrimental bacteria in the intestine  microbiota between healthy individuals and CD patients.  Given that we do not currently understand  whether changes in the types and/ or abundance of microbial community members, or changes in gene content,  or changes in level of expressed protein (or some combination of the three) are most relevant to the  etiology of CD, we believe it is essential to take a more holistic view of this question and examine  microbial community structure and function.&lt;/p&gt;
 </StudyHistory><Attributions><Header title="Principal Investigator"><AttrName>Claire Fraser-Liggett</AttrName><Institution>University of Maryland School of Medicine, Baltimore, MD, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Janet Jannson</AttrName><Institution>University of California, Berkeley, CA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Robert Hettich</AttrName><Institution>Oakridge National Laboratory, Oakridge, TN, USA</Institution></Header><Header title="Funding Source"><AttrName>1UH2DK083991-01</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header></Attributions><Funding>UH2 DK083991-01</Funding></StudyInfo><Authority><ICs><IC id="11" name="NIDDK" is_funding_ic="false" is_admin_ic="false" primary="true"/><IC id="22" name="OD" is_funding_ic="false" is_admin_ic="false"/></ICs><Persons><Person nedid="CMFRASER" aid="2" auth="eRA" login="CMFRASER" fname="Claire" mname="M" lname="Fraser-Liggett" email="cmfraser@som.umaryland.edu"><Role>PI</Role><Organization>UNIVERSITY OF MARYLAND BALTIMOREINSTITUTE FOR GENOMIC RESEARCH</Organization></Person><Person nedid="0010067753" aid="1" auth="cit" login="karpr" fname="Robert" mname="W" lname="Karp" email="karpr@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013043239" aid="1" auth="cit" login="pretels" fname="Renate" mname="S" lname="Pretel" email="pretels@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><DUC><File uri="dbgapssws.cgi?blob_id=6202&amp;file=get&amp;page=file" filename="HMP_GutCrohnsFnc_Fraser_DUC.doc" md5="6632269ad9e3183045b7eede03211835" size="69632" modDate="2010-06-02T16:16:29-05:00" content-type="application/msword"/></DUC><ConsentGroup uid="170" CGType="cg_class_other" title="Microbiome" name="HMP" dac_uid="60" dac_name="NIDDK" irb-approval-required="No"><Use-Restriction>Studies related to the human microbiome.
Sequence data generated from microbiome samples will be used only for the purpose of studying the microbial components of the microbiome and will not be used to make inferences about the human host DNA itself.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>